SUMMARY Although clinical studies suggest that chronic hypercapnic acidosis may be associated with renal sodium retention, little information is available on the effect of acute hypercapnic acidosis on renal sodium excretion. We, therefore, increased Pco 2 from 23 to 74 nun Hg in anesthetized dogs and observed a marked antinatriuresis as absolute sodium excretion (235 to 60 juEq/min, P < 0.001) and fractional excretion of sodium (4.0 to 1.2%, P < 0.02) decreased significantly. This decrease in sodium excretion occurred independent of consistent changes in renal perfusion pressure, Po 2 , glomerular filtration rate, renal blood flow, extraction of p-aminohippuric acid, and filtration fraction. The antinatriuretic response to acute hypercapnic acidosis could be attenuated significantly by surgical renal denervation, intrarenal phenoxybenzamine, and by intrarenal infusion of l-sarcosine,8-glycine angiotensin II. Administration of 10 mg/kg indomethacin enhanced the antinatriuretic response to hypercapnic acidosis in denervated kidneys. These results suggest that renal a-adrenergic nerves and the renin angiotensin system result in an antinatriuretic effect during acute hypercapnic acidosis. Renal prostaglandins or related substances may serve to attenuate this antinatriuretic response. Circ Res 50: [294][295][296][297][298][299][300] 1982 SEVERAL clinical observations have suggested that hypercapnic acidosis is associated with decreased renal sodium excretion. For example, it has long been recognized that patients with chronic lung disease complicated by carbon dioxide retention are more frequently edematous than patients with equivalent airflow obstruction and hypoxemia but with normocapnia (Campbell and Short, 1960) . Moreover, diminished renal sodium excretion has been found when hypercapnic patients with chronic lung disease are compared with normocapnic patients (Farber et al., 1975 (Farber et al., , 1977 . Despite these clinical observations, there are few experimental data on the mechanism of effect of acute hypercapnic acidosis on renal sodium excretion. Therefore, the present studies were carried out to determine the effect of acute hypercapnic acidosis on renal sodium excretion in the anesthetized dog. Several experimental maneuvers were undertaken to clarify efferent mechanisms involved in the observed antinatriuretic effect of hypercapnic acidosis.
SEVERAL clinical observations have suggested that hypercapnic acidosis is associated with decreased renal sodium excretion. For example, it has long been recognized that patients with chronic lung disease complicated by carbon dioxide retention are more frequently edematous than patients with equivalent airflow obstruction and hypoxemia but with normocapnia (Campbell and Short, 1960) . Moreover, diminished renal sodium excretion has been found when hypercapnic patients with chronic lung disease are compared with normocapnic patients (Farber et al., 1975 (Farber et al., , 1977 . Despite these clinical observations, there are few experimental data on the mechanism of effect of acute hypercapnic acidosis on renal sodium excretion. Therefore, the present studies were carried out to determine the effect of acute hypercapnic acidosis on renal sodium excretion in the anesthetized dog. Several experimental maneuvers were undertaken to clarify efferent mechanisms involved in the observed antinatriuretic effect of hypercapnic acidosis.
Methods
Studies were performed on 46 mongrel dogs of either sex weighing 25-35 kg. Food was withheld for 18 hours prior to the experiments, but all animals had free access to water. All dogs were anesthetized with intravenous pentobarbital (20-25 mg/kg) and ventilated with a Harvard respirator (Harvard Apparatus Co.). Ventilatory tidal volume was 15 ml/ kg body weight and respiratory rate was 12-15 ml/ min. Additional small, nonhypotensive doses of pentobarbital were administered throughout the experiments at 30-to 60-minute intervals. Because of striking increases in rate and depth of breathing concurrent with induction of hypercapnic acidosis, all animals were paralyzed with intravenous succinylcholine hydrochloride 0.5-1.0 mg/min throughout the experiment.
Following anesthesia, we inserted polyethylene catheters into both renal veins and ureters through bilateral flank incisions, utilizing a retroperitoneal approach. Two catheters were placed in the aorta via the brachial and femoral artery for continuous monitoring of arterial pressure above and below the renal arteries. Arterial pressure was measured with Statham transducers (Statham Instruments) and recorded continuously on a Gilson multichannel recorder. Arterial blood gases were collected anaer-obically in heparinized syringes and analyzed within a few minutes of sampling on a Corning blood gas analyzer (Corning Scientific Instruments). Catheters were also inserted into the right atrium via an external jugular vein for the injection of cardiogreen dye and into a foreleg vein for infusion of inulin, /j-aminohippuric acid, and fluids. Since alterations in renal perfusion pressure can affect renal sodium excretion, a Blalock clamp was placed around the abdominal aorta above both renal arteries via a retroperitoneal approach to maintain renal perfusion pressure constant in all experiments. In several studies, one kidney was denervated by surgical stripping of all visible renal nerves and adventia from the renal pedicle and application of 95% alcohol . The side of renal denervation was alternated. We have previously validated this denervation procedure by renal tissue biochemical and functional data Berns et al., 1979; Anderson et al., 1980) . After surgery, animals were initially administered a lactated Ringer's solution at a rate of 10-12 ml/ minute for 90 minutes. This infusion rate was then reduced to a rate of 2 ml/min greater than urine flow for the duration of the study. Only animals with basal urinary sodium excretion rates between 100 and 700 juEq/min were included in the study. An intravenous infusion of 0.9% sodium chloride (0.5 ml/min) containing sufficient inulin and p-aminohippuric acid to maintain plasma levels at 15-20 and 1-3 ing/100 ml, respectively, was begun after completion of surgery. To ensure that observed results on sodium excretion were not due to alterations in plasma mineralocorticoid levels, all animals were administered 5 mg of deoxycorticosterone acetate intramuscularly at least 2 hours prior to the start of the experiments.
Experiments were begun 1-2 hours after completion of surgery and stabilization of urine flow. During the experiments, timed urine collections ranged from 5 to 10 minutes, and arterial and renal venous samples were obtained at the midpoint of alternate urine collections. Cardiac output was measured in duplicate during alternate collection periods, using indocyanine green dye and the dye-dilution technique (Schrier et al., 1971) . Hypercapnic acidosis was induced by the addition of 1-2 liters/min 100% carbon dioxide to the intake valve of the ventilator. This method resulted in stable levels of Pco 2 equivalent to values obtained during preliminary experiments utilizing a calibrated Beckman Instrument LB2 capnograph which continuously monitored end-tidal Pco 2 . Experiments were performed according to the following protocols.
Group 1-Time Control Studies (n=7)
These studies were carried out to ensure that the experimental protocol per se did not affect renal sodium excretion. In these experiments, one kidney was denervated in each animal. After stabilization, 3-5 urine and corresponding blood specimens were obtained. After a 30-to 40-minute period of no collections (corresponding to the 30 to 40 minutes allowed for subsequent groups to equilibrate during hypercapnic acidosis), 3-5 additional urine and corresponding blood samples were obtained.
Group 2-Hypercapnic Acidosis with One Kidney Denervated (n=7)
These studies were carried out to determine the effect of hypercapnic acidosis of renal sodium excretion and to assess the role of renal nerves in any observed effect. One kidney was denervated in each dog. After taking 3-5 urine and corresponding blood samples during room air (normocapnia), hypercapnic acidosis was induced. Thirty to 40 minutes later, during continued hypercapnic acidosis, 3-5 additional urine and corresponding blood samples were obtained.
In a separate group of six dogs, a 25-gauge needle was inserted into the left renal artery and thereafter infused with 0.5 ml/min. of normal saline. Three to five urine and corresponding blood samples were obtained. Then phenoxybenzamine (0.2 fig/kg per min) was infused into the renal artery. Subsequent blood and urine specimens were obtained before and 30 minutes after induction of hypercapnia.
Group 3-Hypercapnic Acidosis with Angiotensin II Inhibition of One Kidney (n=8)
These studies were performed because previous experiments indicated that hypercapnic acidosis activates the renin-angiotensin system (Kurz and Zehr, 1978; Anderson et al., 1980) and angiotensin may be antinatriuretic (Johnson and Malvin, 1977) . In these animals, both kidneys were innervated. During surgery, a 25-gauge needle was inserted into the left renal artery and thereafter infused with normal saline at 0.5 ml/min. In these animals, 3-5 urine and corresponding blood collections were obtained. We then started an infusion of 1-sarcosine, 8-glycine angiotensin II (Bachem. Inc.), at 0.1 fig/ kg per min into the left renal artery. Thirty minutes later, an additional set of urine and blood samples were obtained; hypercapnic acidosis was then induced. Thirty to 40 minutes later, during continued hypercapnic acidosis, a third set of urine and blood samples were obtained. The dosage of the angiotensin II inhibitor utilized in this protocol blocks the renal hemodynamic effects but not the systemic hemodynamic effects of 500 ng exogenous angiotensin II in the dog .
To ensure that the angiotensin II inhibitor utilized did not result in a nonspecific effect on urinary sodium excretion, we infused this inhibitor into the renal artery of denvervated kidneys in eight dogs. In these animals, the angiotensin II inhibitor did not alter significantly UnaV (251 ± 33 to 263 ± 45 /iEq/min, NS). VOL.50, No. 2, FEBRUARY 1982 Group 4-Hypercapnic Acidosis with Prostaglandin Inhibition (n-10)
These studies were done to assess the role of prostaglandins in the antinatriuretic response to hypercapnic acidosis. In these studies, one kidney was denervated in each animal. Three to 5 urine samples and corresponding blood samples were obtained before and 30 minutes after indomethacin 10 mg/kg had been administered intravenously. After these latter urine and blood collections, hypercapnic acidosis was induced and a third set of urine and blood samples were obtained 30-40 minutes later. This dose of indomethacin has previously been demonstrated to result in significant decreases in renal tissue prostaglandin levels in the anesthetized dog in our laboratory .
The analytical procedures and calculations used in these experiments have been described in previous publications from this laboratory (Anderson et al., 1975) . Data were analyzed by paired and unpaired Student's £-tests, as appropriate. All data are expressed as the mean ± 1 SEM. (Table 1) Arterial blood gases, mean arterial and renal perfusion pressures, and cardiac output were stable and unchanged in control (group 1) animals. In groups 2, 3, and 4 (hypercapnia) animals, mean maximum Pco 2 values were comparable and ranged from 73 to 74.9 mmHg; this degree of hypercapnia induced similar mean arterial pH values of 7.00 to 7.08. There were no significant changes in Po 2 throughout the study. Mean arterial pressure fell significantly with induction of hypercapnic acidosis in each group of animals. However, renal perfusion pressure was maintained constant in all groups. The combination of decreased arterial pressure and a tendency for cardiac output to increase suggests that hypercapnic acidosis resulted in a decrease in peripheral vascular resistance. Intrarenal phenoxybenzamine, 1-sarcosine, 8-glycine angiotensin II infusion and systemic indomethacin did not significantly affect arterial blood gases or systemic hemodynamics in groups 2, 3, and 4 animals, respectively. Table 2) GFR, RBF, and FF remained stable in group 1 animals with the exception of a significant increase in FF in denervated kidneys. In group 2 animals, a significant decrease in GFR with hypercapnic acidosis occurred in innervated kidneys only, while RBF and FF remained constant in both innervated and denervated kidneys. In group 3 animals, the intrarenal infusion of angiotensin II inhibitor did not alter significantly GFR, RBF, or FF and all of these parameters remained constant with hyper- capnic acidosis in both angiotensin II inhibitor infused and noninfused kidneys. The administration of indomethacin in group 2 animals resulted in significant decreases in RBF in both innervated (282 ± 27 to 230 ± 23 ml/min., p < .05) and denervated kidneys (299 ± 27 to 241 ± 21 ml/min., p < .05) and a significant increase in FF (0.267 to 0.337, p < .05) in denervated kidneys while GFR and FF in innervated kidneys remained constant. As can be observed in Table 2 , in indomethacintreated animals, hypercapnic acidosis resulted in significant decreases in GFR and RBF in innervated kidneys, an effect not observed in paired denervated kidneys. Hypercapnic acidosis decreased PAH extraction in both innervated (0.772 ± 0.04 to 0.703 ± 0.05, P < 0.02) and denervated (0.775 ± 0.04 to 0.690 ± 0.05, P < 0.02) kidneys in group 2 animals. In group 3 animals, hypercapnic acidosis decreased PAH extraction in kidneys infused with the angiotensin II inhibitor (0.721 ± 0.03 to 0.655 ± 0.06 p < .05) but not in the non-infused (0.758 ± 0.03 to 0.747 ± 0.03, NS) kidney. Hypercapnic acidosis decreased PAH extraction in denervated (0.843 ± 0.01 to 0.791 ± 0.01, P < 0.02) kidneys of group 4 animals but not in innervated (0.832 ± 0.01 to 0.806 ± 0.02, NS) kidneys of these animals. (Table 3) Absolute urinary sodium excretion, fractional excretion of sodium, and filtered load of sodium remained constant in innervated and denervated kidneys of group 1 animals. In contrast, hypercapnic acidosis resulted in a striking decrease in absolute and fractional excretion of sodium in innervated kidneys (groups 2 and 3) despite constancy of filtered load of sodium. This antinatriuretic effect of hypercapnic acidosis observed in innervated kidneys could be diminished significantly when the paired kidney was either denervated (group 2) or angiotensin II-inhibited (group 3). Although a small decrease in both absolute and fractional sodium excretion was observed with hypercapnic acidosis in denervated and angiotension II-inhibited kidneys, this decrease was not significant when groups 2 and 3 were analyzed separately. Intrarenal phenoxybenzamine did not significantly alter arterial pressure, cardiac output, GFR, RBF, FF, extraction of PAH and UnaV. As Pco 2 was increased from 24.6 ± 3.0 to 75.8 ± 4.0 mm Hg, mean arterial pressure decreased from 180 ± 5 to 137 ± 4 mm Hg as renal perfusion pressure was maintained constant at 132 mm Hg. Hypercapnic acidosis did not alter significantly GFR, RBF, or FF in either phenoxybenzamine-infused or non-infused kidneys. With hypercapnic acidosis, non-infused kidneys demonstrated a 58 ± 1.6% decrement in basal UnaV which was a significantly (P < 0.001) greater fall than that observed in phenoxybenzamine-infused kidneys (30 ± 3.1%).
Results
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Effects of Hypercapnic Acidosis on Sodium Excretion
In group 4 animals, hypercapnic acidosis resulted in a significant decline in absolute and fractional sodium excretion in both innervated and denervated kidneys. In innervated kidneys, the antinatriuretic effect of hypercapnic acidosis was associated with a significant decrease in filtered load of sodium, an effect not observed in paired denervated kidneys.
Discussion
The effects of hypercapnic acidosis on renal function have been the subject of extensive investigation (Stone et al., 1958; Bersantes and Simmons, 1967; Norman et al., 1970; Farber et al., 1975 Farber et al., , 1976 Farber et al., , 1977 Kurz and Zehr, 1978; Berns et al., 1979; Anderson et al., 1980) . There are suggestions from clinical studies that chronic hypercapnic states are associated with renal sodium retention (Campbell and Short, 1960; Farber et al., 1975; Farber et al., 1977) . Moreover, a recent experimental study suggested that acute hypercapnic acidosis results in antinatriuresis (Norman et al., 1970) .
The antinatriuretic response to hypercapnic acidosis observed in the present study was not associated with significant changes in either filtered load of sodium or peritubular physical factors, as inferred from filtration fraction, felt to be important in modulating tubular sodium reabsorption (Brenner et al., 1973) . Although alterations in intrarenal distribution of RBF may contribute to an antinatriuretic response, the antinatriuresis observed in the present study could be disassociated from the effect of hypercapnic acidosis to decrease PAH extraction. Further, the combination of the rapidity of the antinatriuretic response and administration of pharmacological doses of mineralocorticoid prior to study suggest that increased secretion of aldosterone was not responsible for the antinatriuresis. In view of these findings, several experiments were performed to clarify efferent mechanisms of the antinatriuretic effect of hypercapnic acidosis. The results of the present studies indicate that the mechanisms of the observed antinatriuretic involve several physiological pathways.
Hypercapnic acidosis has been associated with increased peripheral sympathetic nerve activity (Ott et al., 1972) , and studies from several laboratories have demonstrated an important role for renal nerves in mediating renal hemodynamic (Berns et al., 1979; Norman et al., 1970; Stone et al., 1958) and renin secretion responses (Anderson et al., 1980) following hypercapnic acidosis. These observations suggest an effect of hypercapnic acidosis to increase renal nerve traffic. Since renal nerves appear to play a role in directly modulating renal tubular sodium reabsorption (see DiBona, 1977 DiBona, , 1978 Gottschalk et al., 1978 for review), the effect of renal denervation on hypercapnic acidosis associated antinatriuresis was examined. Whereas innervated kidneys demonstrated a consistent antinatriuretic response to hypercapnic acidosis, renal denervation significantly attenuated this response. Moreover, the effect of renal denervation to inhibit the antinatriuretic response to hypercapnic acidosis in the present studies could not be related to a consistent effect of renal denervation to alter glomerular nitration rate, renal blood flow, filtration fraction, and filtered sodium load. However, intrarenal phenoxybenzamine also attenuated the antinatriuresis of hypercapnia. Together these results suggest that a-adrenergic nerves mediate the antinatriuretic response.
The mechanism whereby hypercapnic acidosis increases renal efferent neural traffic in the kidney was not evaluated in the present study. However, hypercapnic acidosis decreased significantly mean arterial pressure, an effect that could, via activation of the baroreceptor reflex, increase efferent renal neural tone (Zambraski et al., 1976) . Thus decreased carotid sinus perfusion results in reflex activation of renal nerves and has been noted to cause an antinatriuresis (Zambraski et al., 1976) . Moreover, this antinatriuresis associated with decreased carotid sinus perfusion occurs independent of altered filtered load of sodium or peritubular physical factors and can be ablated by pharmacological renal denervation (Zambraski et al., 1976) . Taken together, the present and previous studies provide support for the contention that activation of renal nerve activity during hypercapnic acidosis directly increases renal tubular sodium reabsorption. Such an activation of renal nerve activity may be due to the effect of hypercapnic acidosis to lower arterial pressure and diminish carotid sinus perfusion.
Previous studies have indicated an effect of hypercapnic acidosis to activate the renin-angiotensin system (Kurz and Zehr, 1978; Anderson et al., 1980) . Moreover, recent studies suggest that angiotensin II may directly increase renal tubular sodium reabsorption in the dog (Johnson and Malvin, 1977) . Thus, the effect of angiotensin II inhibitor infusion on the antinatriuretic effect following hypercapnic acidosis was examined. In group 3 animals, intrarenal angiotensin II infusion was observed to decrease the antinatriuretic effect of hypercapnic acidosis. This inhibition occurred without significant alterations in filtered load of sodium and renal hemodynamics. Since we did not determine the effect of hypercapnic acidosis on renal sodium excretion in denervated, angiotensin II-inhibited kidneys, we cannot entirely exclude a nonspecific effect of the inhibitor. However, the angiotensin II inhibitor did not alter urinary sodium excretion when administered to either innervated or denervated kidneys during normocapnia. Thus, the results of the present study may suggest that both renal nerves and angiotensin II participate in the increased renal tubular sodium reabsorption following hypercapnic acidosis. It is possible that these factors act synergistically to increase renal tubular sodium reabsorption in this circumstance. In this regard, many studies suggest a role for angiotensin II to facilitate adrenergic neural activity (Zimmerman, 1981) . The results of the present study are compatible with an effect of angiotensin II to facilitate the antinatriuretic effect of renal nerves during hypercapnic acidosis.
The effect of cyclo-oxygenase inhibition on urinary sodium excretion during hypercapnic acidosis was also examined in the present studies. Despite numerous previous investigations (see Epstein and Lifschitz, 1980; Kirschenbaum and Serros, 1980, for review) , the effect of prostaglandins and related substances in mediating alterations in renal sodium excretion remain unclear. Although many studies have examined the effect of cyclo-oxygenase inhibition with nonsteroidal anti-inflammatory agents on the renal response to maneuvers which increase renal sodium excretion (Epstein and Lifschitz, 1980; Kirschenbaum and Serros, 1980) , few studies have utilized cyclo-oxygenase inhibition with maneuvers that diminish renal sodium excretion (DeForrest et al., 1980) . In the present studies, hypercapnic acidosis resulted in a significant decrease in absolute VOL.50, No.2, FEBRUARY 1982 and fractional sodium excretion in both innervated and denervated kidneys in animals pretreated with indomethacin. The mechanism of effect of indomethacin to decrease sodium excretion in innervated kidneys cannot be determined with certainty, since a significant decrease in glomerular filtration rate, renal blood flow, and filtered load of sodium was present. However, in denervated kidneys of group 2 (non-indomethacin treated) animals, no alteration of sodium excretion was observed during hypercapnic acidosis. In contrast, the denervated kidneys of group 4 indomethacin-treated dogs exposed to hypercapnic acidosis were noted to decrease sodium excretion independently of a significant change in GFR, RBF, or FF. Thus, these findings suggest that either one of the prostaglandins or a related substance distal to the site of cyclooxygenase plays a natriuretic role in this model of hypercapnic acidosis.
In summary, the results of the present study suggest an interaction of renal nerves, angiotensin II, and a prostaglandin or related substance in mediating the antinatriuretic response to hypercapnic acidosis. Hypercapnic acidosis may result in an increase in renal a-adrenergic neural traffic to the kidney via either a direct effect of hypercapnic acidosis or by an effect of hypercapnic acidosis to lower mean arterial pressure. This results in an increase in renal nerve and renin-angiotensin system activity (Anderson et al., 1980) . These factors exert an antinatriuretic effect independent of renal hemodynamic effects. Renal prostaglandins may be stimulated by the increase in renal nerve activity or by angiotensin and play a natriuretic role in this model, an effect unmasked by cyclo-oxygenase inhibition.
